Journal article
Early and Late Effects of Clopidogrel in Patients With Acute Coronary Syndromes
Abstract
BACKGROUND: The risk of ischemic events is high, both early and late after acute coronary syndromes (ACS). We examine the benefits and risks associated with the use of adding clopidogrel to aspirin within the first 30 days and later (31 days to 12 months) in 12 562 patients with ACS.
METHODS AND RESULTS: A total of 12 562 ACS patients were randomized to receive clopidogrel (300 mg initially followed by 75 mg/d) or placebo for 3 to 12 months. …
Authors
Yusuf S; Mehta SR; Zhao F; Gersh BJ; Commerford PJ; Blumenthal M; Budaj A; Wittlinger T; Fox KAA
Journal
Circulation, Vol. 107, No. 7, pp. 966–972
Publisher
Wolters Kluwer
Publication Date
February 25, 2003
DOI
10.1161/01.cir.0000051362.96946.15
ISSN
0009-7322